Immuno-Oncology Services

Partner with us to drive pioneering research, develop cutting-edge therapies, and create tailored in vitro assay solutions in the fight against cancer. Our expertise spans immunotherapy, antibody-drug conjugates (ADCs), and bispecific antibodies (BsAbs).

Join forces with us to drive groundbreaking research, develop cutting-edge therapies, and create personalized solutions in the fight against cancer. By collaborating with us, you gain access to:

Expertise and Innovation: Leverage our extensive experience and innovative approaches in in vitro studies.

Customized Solutions: Benefit from tailored research and therapy development that meets your specific needs.

Advanced Technologies: Utilize state-of-the-art technologies and methodologies to enhance your research outcomes.

Accelerated Timelines: Achieve faster results with our efficient and streamlined processes.

Speak to our experts

Our service range includes:

Biochemical Assays

Antigen-antibody binding assay (Protein-based ELISA)
Cell-based FACS for binding assay
Signal transduction (Phospho-Flow, phosphorylation by western blot, p-ELISA)
Enzyme activity assays

Cellular assays

T cell activation (anti-CD3/CD28 stimulation plate bound, soluble, bead-based)
Tumor-dependent immune system activation (BsAb binding assay, cytotoxicity assay)
Fc-dependent killing and phagocytosis assay (ADCC. ADCP, CDC by FACS, Incucyte)
Fc-independent killing assay (CD3xTAA bispecific ab-based killing, T cell-specific killing, NK-mediated killing, CAR-T killing, MLR)
Cytotoxicity assays (FACS/ INCUCYTETM/ CellTitre-glo/ MTT)
Cell cycle analysis
Macrophage differentiation/polarization (M1/M2)
Antibody internalization (Direct detection by FACS or pHrodo-based detection by FACS or incucyte)
Surface marker and target expression profiling
Cytokine profiling by FACS/ELISA/rt-PCR
In vitro expansion of Tregs, T cell suppression assay

Why Aurigene Immuno-Oncology Services?

State-of-the-art facilities with high-end instrumentation

Wide range of tools under a single umbrella

Customized generation of related reagents

Fast and innovative solutions

One-stop solution for tailored in vitro assays

Virtual Tour

Hyderabad R and D Center

Bangalore R and D Center

Connect with our scientific experts for your drug discovery, development, and manufacturing needs

We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.

Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

I agree to receive updates from Aurigene

* I agree and accept the Privacy Policy and Terms of Use of this website.

Page name

page url

Learning Resources

Transforming Drug Discovery with Aurigene.AI

In the early 2000s, developing Sovaldi, a hepatitis C treatment, took over a decade and nearly $2 billion. Similarly, Zolgensma, a gene therapy for spinal muscular atrophy, required 15 years due to its complexity. However, the advent of artificial intelligence (AI) has revolutionized drug discovery. For example, in 2022, Pfizer's PAXLOVID, an oral COVID-19 treatm...

View All

Advancement in personalized medicine and how the CRDMO industry is part of the solution

Personalized medicine is transforming the healthcare landscape by customizing treatment plans to individual patients’ unique genetic, clinical and environmental characteristics. These are effective and less invasive treatments for a wide range of conditions. Contract Research, Development and Manufacturing Organizations (CRDMOs) play an important role in enabli...

View All

High Potent API (HPAPI) Manufacturing Services

Aurigene Pharmaceutical Services has experience, expertise and infrastructure to develop and manufacture oncology drug candidates including HPAPI ...

View All

Technology meets sustainability - How a complex API development process goes green

We are always looking for ways to enhance the sustainability of our products and services. Our team successfully developed a scalable manufacturing process for the API product of one of our Biotech clients using eco-friendly manufacturing technologies. Read the case study to learn more....

View All

Formal synthesis of Cladospolide C & epi-Cladospolide C using R- (þ)-g-valerolactone as a chiral synthon

2019

The formal synthesis of Cladospolide-C and its analog is achieved by using enantiopure (R)-g evalerolactone 10. The significant points of this synthesis are the stereoselective dihydroxylation of a, bunsaturated ester 16 using Sharpless protocol, Wittig olefination of g evalerolactol 6 with triphenylphosphonium iodide salt 7, one pot selective oxidation ...

Development and assessment of a Bcs class II - SGLT2 (Sodium Glucose Cotransporter 2) inhibitor drug in the form of solid lipid Nanoparticles by selecting different lipids, co-surfactants, and manufacturing techniques

Drug Delivery System (DDS) has been used successfully in the past few decades to cure illnesses and enhance health because of its improved systemic circulation and ability to regulate the drug's pharmacological action. As pharmacology and pharmacokinetics advanced, the idea of controlled release emerged, demonstrating the significance of drug release in assessing...
Read More
Development of novel paullone-based PROTACs as anticancer agents

Proteolysis-targeting chimera (PROTACs) represents a promising modality that has gained significant attention for cancer treatment. Using PROTAC technology, we synthesized novel structurally modified paullone-based PROTACs using Cereblon (CRBN) and Von Hippel–Lindau (VHL) E3 ligands....
Read More
Development and verification of RP-HPLC method for the quantitative determination of Decitabine in tablet dosage formulation

Decitabine is an anti-cancer chemotherapy drug. This article describes method development and method verification of Assay of Decitabine in tablet formulation. A new, precise, rapid, accurate RP-HPLC method has been developed for the estimation of Decitabine in pharmaceutical tablets dosage form. After optimization the good chromatographic separation was achieved...
Read More

View All

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

Proceed Back